{"id":998337,"date":"2026-08-26T16:20:06","date_gmt":"2026-08-26T20:20:06","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences\/"},"modified":"2026-08-26T16:20:06","modified_gmt":"2026-08-26T20:20:06","slug":"first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences\/","title":{"rendered":"First Tracks Biotherapeutics Announces Participation in September Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SAN DIEGO, Aug.  26, 2026  (GLOBE NEWSWIRE) &#8212; First Tracks Biotherapeutics, Inc. (Nasdaq: TRAX), a clinical-stage biotechnology company advancing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases, today announced that members of its executive team are scheduled to participate in multiple upcoming investor conferences:<\/p>\n<p>\n        <strong>21<\/strong><br \/>\n        <sup><br \/>\n          <strong>st<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Wells Fargo Healthcare Conference, Boston<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li>Format \u2013 Fireside chat and one-on-one investor meetings<\/li>\n<li>Date and Time \u2013 Wednesday, Sept. 9, 2026 at 9:30am ET \/ 6:30am PT<\/li>\n<\/ul>\n<p>\n        <strong>Citi&#8217;s 2026 Biopharma Back to School Conference, New York City<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li>Format \u2013 One-on-one investor meetings<\/li>\n<li>Date and Time \u2013 Thursday, Sept. 10, 2026<\/li>\n<\/ul>\n<p>\n        <strong>Morgan Stanley 24th Annual Global Healthcare Conference, New York City<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li>Format \u2013 One-on-one investor meetings<\/li>\n<li>Date and Time \u2013 Wednesday, Sept. 16, 2026<\/li>\n<\/ul>\n<p>A live webcast of the fireside chat will be available on the investor section of the First Tracks website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NNg6fiSBbwZO_ZbDT-TyTJwH3y4BVztpLuWHsqEZ3cOmorRVvMZosvLML1RB62l86RFUl5Mvzr89npqoZSM6p6da9REOlhayvHkcykLFIVH11mk7CuxzH64lkyqSvREeDdxErevLjwMtZTLuLQHrAVld7qtR78jQ91BXnrvds-g=\" rel=\"nofollow\" target=\"_blank\">https:\/\/ir.firsttracksbio.com\/news-events\/events<\/a>. A replay of the webcast will be available for at least 30 days following the event.<\/p>\n<p>\n        <strong>About First Tracks Biotherapeutics<\/strong>\n      <\/p>\n<p>First Tracks Biotherapeutics is a clinical stage biotechnology company advancing antibody therapies that modulate immune pathways implicated in autoimmune and inflammatory diseases. Its pipeline includes ANB033, a CD122 antagonist in development for celiac disease and eosinophilic esophagitis; rosnilimab, a pathogenic T cell depleter in development for rheumatoid arthritis; and ANB101, a BDCA2 modulator. To learn more, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=L2Jy2DBrddAI6G72qlLUc2tw0Ju0J_bMBvrc-mDsp9LK3Wkw-Yul6IwLIi-OqmzdVse7-IdSUz4IQaHH0KS-VP835tM-LblkvrrYxguNY1g=\" rel=\"nofollow\" target=\"_blank\">www.FirstTracksBio.com<\/a> or follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OlXRiocrC_jtszX3nEy4XUfI_sJyWwzlV_VzmifZJzuagz5NvuOAj5HMyhT6Kwji0yBzExeA54XEyp59RK9IH32Q4_0p2YRFIPEi-YlZ5rmZDYeJGKnaXOVzM4Z-WluM\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Nick Montemarano<br \/>Vice President, Investor Relations<br \/>858.732.0178<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DZCWPlpD_zL3EcOVMou4H7pLeVZJefEXpfVF25B-BDAVhqZng6bi6rOSer2VnIkBVQQ6Vi0Hz3wy2_1SIA6TcZsY7mK2_r77SNwsAfHJZ9oiV33z2gB-UfuqsnDvTMoR\" rel=\"nofollow\" target=\"_blank\">investors@firsttracksbio.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjU0NSM3ODA0NDkzIzIzMDk5ODg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/Y2RmZDg5NzctNDA4Ni00NDkwLWIzYjAtMTRmMTk4ZjBjYjBiLTEzMjE1MzgtMjAyNi0wOC0yNi1lbg==\/tiny\/First-Tracks-Biotherapeutics-I.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, Aug. 26, 2026 (GLOBE NEWSWIRE) &#8212; First Tracks Biotherapeutics, Inc. (Nasdaq: TRAX), a clinical-stage biotechnology company advancing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases, today announced that members of its executive team are scheduled to participate in multiple upcoming investor conferences: 21 st Annual Wells Fargo Healthcare Conference, Boston Format \u2013 Fireside chat and one-on-one investor meetings Date and Time \u2013 Wednesday, Sept. 9, 2026 at 9:30am ET \/ 6:30am PT Citi&#8217;s 2026 Biopharma Back to School Conference, New York City Format \u2013 One-on-one investor meetings Date and Time \u2013 Thursday, Sept. 10, 2026 Morgan Stanley 24th Annual Global Healthcare Conference, New York City Format \u2013 One-on-one investor meetings Date and Time \u2013 &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;First Tracks Biotherapeutics Announces Participation in September Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-998337","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>First Tracks Biotherapeutics Announces Participation in September Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"First Tracks Biotherapeutics Announces Participation in September Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Aug. 26, 2026 (GLOBE NEWSWIRE) &#8212; First Tracks Biotherapeutics, Inc. (Nasdaq: TRAX), a clinical-stage biotechnology company advancing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases, today announced that members of its executive team are scheduled to participate in multiple upcoming investor conferences: 21 st Annual Wells Fargo Healthcare Conference, Boston Format \u2013 Fireside chat and one-on-one investor meetings Date and Time \u2013 Wednesday, Sept. 9, 2026 at 9:30am ET \/ 6:30am PT Citi&#8217;s 2026 Biopharma Back to School Conference, New York City Format \u2013 One-on-one investor meetings Date and Time \u2013 Thursday, Sept. 10, 2026 Morgan Stanley 24th Annual Global Healthcare Conference, New York City Format \u2013 One-on-one investor meetings Date and Time \u2013 &hellip; Continue reading &quot;First Tracks Biotherapeutics Announces Participation in September Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-26T20:20:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjU0NSM3ODA0NDkzIzIzMDk5ODg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"First Tracks Biotherapeutics Announces Participation in September Investor Conferences\",\"datePublished\":\"2026-08-26T20:20:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences\\\/\"},\"wordCount\":236,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNjU0NSM3ODA0NDkzIzIzMDk5ODg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences\\\/\",\"name\":\"First Tracks Biotherapeutics Announces Participation in September Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNjU0NSM3ODA0NDkzIzIzMDk5ODg=\",\"datePublished\":\"2026-08-26T20:20:06+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNjU0NSM3ODA0NDkzIzIzMDk5ODg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNjU0NSM3ODA0NDkzIzIzMDk5ODg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"First Tracks Biotherapeutics Announces Participation in September Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"First Tracks Biotherapeutics Announces Participation in September Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"First Tracks Biotherapeutics Announces Participation in September Investor Conferences - Market Newsdesk","og_description":"SAN DIEGO, Aug. 26, 2026 (GLOBE NEWSWIRE) &#8212; First Tracks Biotherapeutics, Inc. (Nasdaq: TRAX), a clinical-stage biotechnology company advancing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases, today announced that members of its executive team are scheduled to participate in multiple upcoming investor conferences: 21 st Annual Wells Fargo Healthcare Conference, Boston Format \u2013 Fireside chat and one-on-one investor meetings Date and Time \u2013 Wednesday, Sept. 9, 2026 at 9:30am ET \/ 6:30am PT Citi&#8217;s 2026 Biopharma Back to School Conference, New York City Format \u2013 One-on-one investor meetings Date and Time \u2013 Thursday, Sept. 10, 2026 Morgan Stanley 24th Annual Global Healthcare Conference, New York City Format \u2013 One-on-one investor meetings Date and Time \u2013 &hellip; Continue reading \"First Tracks Biotherapeutics Announces Participation in September Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-08-26T20:20:06+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjU0NSM3ODA0NDkzIzIzMDk5ODg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"First Tracks Biotherapeutics Announces Participation in September Investor Conferences","datePublished":"2026-08-26T20:20:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences\/"},"wordCount":236,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjU0NSM3ODA0NDkzIzIzMDk5ODg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences\/","name":"First Tracks Biotherapeutics Announces Participation in September Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjU0NSM3ODA0NDkzIzIzMDk5ODg=","datePublished":"2026-08-26T20:20:06+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjU0NSM3ODA0NDkzIzIzMDk5ODg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjU0NSM3ODA0NDkzIzIzMDk5ODg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-september-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"First Tracks Biotherapeutics Announces Participation in September Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/998337","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=998337"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/998337\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=998337"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=998337"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=998337"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}